Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 12,644 shares at $46.29 ($585K) on 2025-09-08, disclosed to the SEC on 2025-09-09.
Scheduled sale ($585k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 6,322 | $293K | 50.0% |
| 2 | $46.29 | 6,322 | $293K | 50.0% |
| Total | $46.29 avg | 12,644 | $585K | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |